Heterogeneous nuclear ribonucleoprotein A1 pseudogene 55 (HNRNPA1P55)

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 55 (HNRNPA1P55) is classified as a pseudogene in the human genome. It shares sequence similarity with the gene encoding HNRNPA1, a key RNA-binding protein involved in several aspects of RNA splicing, transport, and gene regulation[1][5][9]. However, HNRNPA1P55 itself has acquired mutations that prevent it from encoding a functional protein. While some pseudogenes can be transcribed and play regulatory roles as non-coding RNAs, no functional role has been documented for HNRNPA1P55 specifically. It is not considered a therapeutic target, receptor, enzyme, or biotechnology tool in current biomedical practice[1][4]. Key distinction: - HNRNPA1P55 is distinct from its parental gene HNRNPA1, which *is* an RNA-binding protein with well-established roles in RNA metabolism, regulation, and disease, and is researched as a cancer biomarker and potential therapeutic target[3][6][9]. - HNRNPA1P55, as a pseudogene, lacks such roles or actionable target potential. In summary, HNRNPA1P55 is a pseudogene, not a functional receptor or druggable target. All therapeutic or functional claims in the literature are linked to HNRNPA1 (the protein-coding gene), not this pseudogene variant[1][4].

Other names

HNRNPA1P55heterogeneous nuclear ribonucleoprotein A1 pseudogene 55